Cancer Centers Support Grants federal funding in FY2024

How CFDA 93.397 meets fiscal year 2024 in the award file

The join is Cancer Centers Support Grants × FY2024. $8,086,150,903.98 sits only where CFDA 93.397 and fiscal year 2024 overlap in the yearlyTrend extract. Open /programs/93.397/ (CFDA 93.397) for the program table without this FY2024 filter, and /fiscal-years/2024/ (FY2024 federal spending) for the year table without this CFDA filter. Those hubs are parents, not addends to $8,086,150,903.98. The pair is not cancer treatment research (a different CFDA), a hospital-bed census, or a named-center list.

Read /programs/93.397/ (CFDA 93.397) for the program rollup, /fiscal-years/2024/ (FY2024 federal spending) for the year rollup, /programs/ (All programs) for every CFDA hub, and /ties/ (All spending ties) for the rest of the join list. Do not add those pages into $8,086,150,903.98. Recipients are unpublished. Two hundred sixty-five FY2024 awards is not 265 unique designated centers. Continuation awards add rows.

What CFDA 93.397 labels in FY2024

USAspending labels CFDA 93.397 as Cancer Centers Support Grants. That code produced $8,086,150,903.98 when crossed with fiscal year 2024. The program-wide hub does not require a FY2024 filter. The year hub does not require this CFDA. Only this tie applies both filters. The CFDA title is CANCER CENTERS SUPPORT GRANTS. Core-grant versus other cancer-center instruments are not split in this yearlyTrend cell. FY2024 figures can still move after deobligations or recoveries.

FY2024 cancer-center support obligations are not trial enrollments

FY2024 on USAspending.gov is a federal fiscal year, not a calendar year and not a state fiscal year. $8,086,150,903.98 is the Cancer Centers Support Grants slice of that year in this extract, not the government-wide FY2024 total. FY2024 figures can still move after deobligations or recoveries. Prefer /fiscal-years/2024/ if the live year table moved. Outlays are unpublished.

265 FY2024 awards are not 265 cancer centers

265 is the FY2024 award-record count published on this pair. 290 is the program-extract award-record count across years. Dividing $8,086,150,903.98 by 290 would mix a one-year dollar total with a multi-year row count, so this page does not publish that ratio as a typical award. Unique recipients are unpublished. Two hundred sixty-five FY2024 awards is not 265 unique designated centers. Continuation awards add rows.

Treat 265 as award records on the FY2024 cell, not unique vendors and not a an NCI-designated center directory, a trial-enrollment table, or a campus roster. Do not per-capita or per-recipient the dollar total; those denominators are unpublished. FEC contribution tables do not fund these awards. Cancer-center names, campuses, and investigators are unpublished on this packet.

Center rankings this join cannot support

Budget justifications, program evaluation reports, and press releases answer other questions. They are not the source of this cell. If a chart mixes cancer treatment research (a different CFDA), a hospital-bed census, or a named-center list with CFDA 93.397 in FY2024, the chart has left this join. Cancer-center names, campuses, and investigators are unpublished on this packet.

Cite USAspending.gov: Cancer Centers Support Grants (CFDA 93.397) obligated $8,086,150,903.98 in FY2024. Name Cancer Centers Support Grants and FY2024 together. Keep the obligation word. If /programs/93.397/ or /fiscal-years/2024/ has refreshed, prefer the live hub over this snapshot for current rows. The pair is not a center directory, a trial roster, or an outlay register. 97.4% of $8,305,216,099.12 is the program share on this packet, not a budget score.

Reading Cancer Centers Support beside FY2024

Open CFDA 93.397 for the program rollup, FY2024 federal spending for the fiscal-year rollup, All programs for other CFDA hubs, and All spending ties for other pairs. None of those links convert this cell into cancer treatment research (a different CFDA), a hospital-bed census, or a named-center list, into outlays this packet omits, or into a contractor list. Cite both sides: Cancer Centers Support Grants and FY2024, $8,086,150,903.98, USAspending.gov, obligations only. CFDA 93.397 remains the program key.

Questions

How much did Cancer Centers Support Grants show in federal obligations in FY2024?

USAspending.gov records $8,086,150,903.98 in Cancer Centers Support Grants obligations for FY2024 (CFDA 93.397). That is an obligation aggregate for the program-year pair, not an outlay and not the government-wide FY2024 total. Original filings remain on USAspending.gov.

Is Cancer Centers Support Grants FY2024 cash already paid to campuses?

No. $8,086,150,903.98 is a yearlyTrend obligation sum, not an outlay. Payments from the Treasury can lag or differ. This packet has no outlay total for Cancer Centers Support Grants in FY2024. Original filings remain on USAspending.gov.

Do 265 awards mean 265 NCI cancer centers?

No. 265 is the FY2024 award-record count on this pair, not a published unique-recipient census. The program extract lists 290 awards across years. Modifications can add rows. Original filings remain on USAspending.gov. Keep both the CFDA number and the fiscal year in the citation.

Which pages parent Cancer Centers Support Grants FY2024?

The CFDA 93.397 hub is the program parent. The FY2024 federal-spending hub is the year parent. All programs lists CFDA hubs. All spending ties lists other pairs. Prefer those tables after later ingests; this page quotes Cancer Centers Support Grants × FY2024 at $8,086,150,903.98.